Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Environ Res. 2021 Apr 20;197:111165. doi: 10.1016/j.envres.2021.111165

Table 4:

Associations between maternal inflammatory biomarkers during pregnancy and infant birth and adiposity outcomes.

Birth weight (g) (n=515) Gestational age (days) (n=515) Adiposity at birth (%) (n=497) Adiposity at postnatal (~5 months) follow-up (%) (n=334)

β (95% CI) per log-unita β (95% CI) per log-unita β (95% CI) per log-unita β (95% CI) per log-unitb
CRP (mg/L) 12.48 (−31.31, 56.27) 1.30 (0.40, 2.21) 0.06 (−0.34, 0.45) 0.43 (−0.26, 1.12)
IL-6 (pg/mL) 10.51 (−66.94, 87.95) 0.24 (−1.37, 1.86) 0.23 (−0.47, 0.93) −0.04 (−1.30, 1.21)
TNFα (pg/mL) 23.30 (−22.72, 69.31) 0.29 (−0.67, 1.25) −0.11 (−0.53, 0.31) −0.14 (−0.91, 0.63)

Abbreviations: 95% CI, 95% Confidence Interval; CRP, C-reactive protein; IL-6 interleukin-6; TNFα, tumor necrosis factor-α

All maternal inflammatory biomarker outcomes were natural log transformed.

a

Adjusted for race, maternal age, median income in the Census tract, pre-pregnancy BMI, education, smoking status, gestational age at sample collection, infant sex, and parity.

b

Additionally adjusted for infant age at the time of adiposity measurement.